Monday, 19 October 20269:21 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Business

Divi's Laboratories shares in focus as weight loss drug receives EU panel backing

Image: Cnbctv18. Rights remain with the publisher.

Analysts believe Divi's Laboratories is likely to be the intermediate supplier of orforglipron for weight loss. The stock may see a reaction in today's trading session.

Read the full report on Cnbctv18

Story file

Section
Business
Topics
Stock market
First reported by
Cnbctv18
Reporter
shloka badkar
Published
Monday, 19 October 2026, 8:08 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Cnbctv18 with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Business news

See all